secwatch.observer — SEC 8-K summary
======================================

Issuer:     Biofrontera Inc. (BFRI)
CIK:        0001858685
Form:       8-K
Filed at:   2026-08-13T13:00:44+00:00
Accession:  0001493152-26-037610
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biofrontera Q2 revenue up 33% to $12.0M; net loss narrows to $0.6M
------------------------------------------------------------------

- Q2 net product revenue $12.0M, up 32.9% YoY; gross margin 80% vs 71% prior year.
- Net loss narrowed to $0.6M ($0.05/share) from $5.3M ($0.57/share); Adjusted EBITDA $(0.2)M vs $(5.1)M.
- H1 revenue $22.1M (+25.4%); operating cash use cut 76% to $1.7M; cash $4.7M at June 30.
- ITC exclusion order on RhodoLED XL lamp effective July 7, 2026; remediation plan underway, full-year revenue goals unchanged.
- PDUFA date late September 2026 for sBCC indication; launch expected Q1 2027 if approved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858685/000149315226037610/0001493152-26-037610-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858685/000149315226037610/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-037610

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer